Canandaigua National Corp Charles River Laboratories International, Inc. Transaction History
Canandaigua National Corp
- $589 Million
- Q4 2022
A detailed history of Canandaigua National Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Canandaigua National Corp holds 1,187 shares of CRL stock, worth $211,974. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,187
Previous 1,184
0.25%
Holding current value
$211,974
Previous $233,000
11.16%
% of portfolio
0.04%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding CRL
# of Institutions
719Shares Held
52MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.09 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$909 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$373 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$341 Million0.99% of portfolio
-
Allspring Global Investments Holdings, LLC1.76MShares$314 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.08B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...